Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Intranasal Amphotericin B Suspension in Patients With Refractory, Postsurgical Chronic Sinusitis (CS)

NCT00425620 is registered in ClinicalTrials.gov with Accentia Biopharmaceuticals as lead sponsor.

NCT NCT00425620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Intranasal Amphotericin B Suspension in Patients With Refractory, Postsurgical Chronic Sinusitis (CS)
Lead sponsor
Accentia Biopharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
October 31, 2007
Enrollment
300 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

chronic sinusitis